You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-refractory Refractory Multiple Myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

Completed
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Relapsed or Refractory Multiple Myeloma
  • BEBT-908 for injection
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 9, 2023

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • GIC-102 (Allogeneic NK cells)
  • Gyeonggi-do, Korea, Republic of
  • +3 more
May 18, 2023

Patients With Relapsed/Refractory Multiple Myeloma

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma (RRMM)
  • Non-Interventional
  • (no location specified)
Dec 21, 2022

Relapsed and/or Refractory Multiple Myeloma Trial in China (ICP-490)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +4 more
Jan 30, 2023

Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma Trial in Zhengzhou, Shengyang, Hangzhou (HRS-3738)

Recruiting
  • Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
  • Zhengzhou, Henan, China
  • +2 more
Jul 27, 2022

Myeloma Multiple Trial (Off Drug Surveillance)

Not yet recruiting
  • Myeloma Multiple
  • Off Drug Surveillance
  • (no location specified)
Jun 27, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

Multiple Myeloma, Lymphoma, Non-Hodgkin's Trial in United States (CFT7455, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma
  • Lymphoma, Non-Hodgkin's
  • Phoenix, Arizona
  • +12 more
Dec 12, 2022

Relapsed and/or Refractory Multiple Myeloma, Relapsed and/or Refractory Non Hodgkin Lymphoma Trial in United States (MT-0169)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Relapsed and/or Refractory Non Hodgkin Lymphoma
  • Los Angeles, California
  • +6 more
Feb 28, 2022

Non-interventional Study With Pomalidomide (Imnovid®)

Completed
  • Multiple Myeloma
    • Freiburg, Baden-Wuerttemberg, Germany
      iOMEDICO AG
    Aug 11, 2022

    Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

    Recruiting
    • Non-Hodgkin Lymphoma (NHL)
    • +2 more
    • Gent, Belgium
    • +9 more
    Mar 18, 2022

    Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Non-Hodgkin's Lymphoma
    • Hartford, Connecticut
    • +6 more
    Jan 3, 2023

    Multiple Myeloma Trial in Zhengzhou (PD1-BCMA-CART)

    Not yet recruiting
    • Multiple Myeloma
    • PD1-BCMA-CART
    • Zhengzhou, Henan, China
      First Affliated Hospital of Zhengzhou University
    May 15, 2022

    Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

    Completed
    • Multiple Myeloma
    • +3 more
    • Denver, Colorado
    • +4 more
    Nov 14, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Seattle (Nivolumab)

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +17 more
    • Nivolumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2022

    Relapsed Refractory Multiple Myeloma Trial in India (Drug: Carfilzomib + Dexamethasone, Drug: Carfilzomib + Lenalidomide +

    Active, not recruiting
    • Relapsed Refractory Multiple Myeloma
    • Drug: Carfilzomib + Dexamethasone
    • Drug: Carfilzomib + Lenalidomide + Dexamethasone
    • Hyderabad, Andhra Pradesh, India
    • +16 more
    Dec 13, 2022

    Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

    Recruiting
    • Myelodysplastic Syndrome
    • +16 more
    • Computed Tomography
    • +6 more
    • Scottsdale, Arizona
    • +2 more
    Feb 3, 2022

    Multiple Myeloma Trial (CM313 injection)

    Not yet recruiting
    • Multiple Myeloma
    • CM313 injection
    • (no location specified)
    Nov 6, 2023

    Multiple Myeloma Trial (AZD0305)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 24, 2023

    Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

    Recruiting
    • Plasma Cell Myeloma
    • +3 more
    • Behavioral Intervention
    • +6 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 5, 2022

    Relapsed/Refractory Multiple Myeloma With Pomalidomide in

    Recruiting
    • Multiple Myeloma
    • Feldkirch, Austria
    • +12 more
    May 16, 2022